Malignant neoplasm of breast
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We show that FoxG1 expression is low in breast cancer cell lines and that low levels of FoxG1 are correlated with a worse prognosis in breast cancer.
|
23660594 |
2013 |
Breast Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We show that FoxG1 expression is low in breast cancer cell lines and that low levels of FoxG1 are correlated with a worse prognosis in breast cancer.
|
23660594 |
2013 |
Movement Disorders
|
0.150 |
GeneticVariation
|
group |
BEFREE |
We screened the entire coding region of the gene for mutations in 50 boys with congenital encephalopathy, postnatal microcephaly, and complex movement disorders, a clinical picture very similar to that described in girls with FOXG1 mutations.
|
20734096 |
2011 |
Microcephaly
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We screened the FOXG1 gene in a cohort of 206 MECP2 and CDKL5 mutation negative patients (136 females and 70 males) with severe encephalopathy and microcephaly.
|
19806373 |
2010 |
Encephalopathies
|
0.070 |
GeneticVariation
|
group |
BEFREE |
We screened the FOXG1 gene in a cohort of 206 MECP2 and CDKL5 mutation negative patients (136 females and 70 males) with severe encephalopathy and microcephaly.
|
19806373 |
2010 |
Intellectual Disability
|
0.410 |
GeneticVariation
|
group |
BEFREE |
We recommend that patients with congenital RTT and Rett-like MR, especially those with brain malformations, such as hypoplasia of the corpus callosum, should be tested for FOXG1 mutations.
|
28851325 |
2017 |
Mental Retardation
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We recommend that patients with congenital RTT and Rett-like MR, especially those with brain malformations, such as hypoplasia of the corpus callosum, should be tested for FOXG1 mutations.
|
28851325 |
2017 |
Rett Syndrome
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
We recommend that patients with congenital RTT and Rett-like MR, especially those with brain malformations, such as hypoplasia of the corpus callosum, should be tested for FOXG1 mutations.
|
28851325 |
2017 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
We now report a 3-year-old FOXG1-duplicated patient with a yet undescribed tumor syndrome with clinical features of neurofibromatosis types I and II, where several validation studies could not ascertain the significance of CES findings; further studies may elucidate precise mechanisms and diagnosis for clinical management, including tumor surveillance.
|
26542077 |
2016 |
Neurofibromatosis 1
|
0.010 |
Biomarker
|
disease |
BEFREE |
We now report a 3-year-old FOXG1-duplicated patient with a yet undescribed tumor syndrome with clinical features of neurofibromatosis types I and II, where several validation studies could not ascertain the significance of CES findings; further studies may elucidate precise mechanisms and diagnosis for clinical management, including tumor surveillance.
|
26542077 |
2016 |
Neurofibromatoses
|
0.010 |
Biomarker
|
group |
BEFREE |
We now report a 3-year-old FOXG1-duplicated patient with a yet undescribed tumor syndrome with clinical features of neurofibromatosis types I and II, where several validation studies could not ascertain the significance of CES findings; further studies may elucidate precise mechanisms and diagnosis for clinical management, including tumor surveillance.
|
26542077 |
2016 |
Movement Disorders
|
0.150 |
GeneticVariation
|
group |
BEFREE |
We identified patients with FOXG1 mutations who were referred to either a tertiary movement disorder clinic or tertiary epilepsy service and retrospectively reviewed medical records, clinical investigations, neuroimaging, and available video footage.
|
27029630 |
2016 |
Rett Syndrome
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
We have identified a novel mutation (p. D263VfsX190) in FOXG1 gene in a patient with congenital variant of Rett syndrome.
|
24412290 |
2014 |
FOXG1 syndrome
|
0.790 |
GeneticVariation
|
disease |
BEFREE |
We expand the mutational spectrum in patients with FOXG1-related encephalopathies and precise the core FOXG1 syndrome phenotype.
|
22739344 |
2012 |
Encephalopathies
|
0.070 |
Biomarker
|
group |
BEFREE |
We expand the mutational spectrum in patients with FOXG1-related encephalopathies and precise the core FOXG1 syndrome phenotype.
|
22739344 |
2012 |
FOXG1 syndrome
|
0.790 |
Biomarker
|
disease |
BEFREE |
We believe the FOXG1 position effect largely accounts for the clinical phenotype in DGAP294, which can be classified as FOXG1 syndrome like.
|
29321672 |
2018 |
Rett Syndrome
|
0.300 |
Biomarker
|
disease |
BEFREE |
We believe that the FOXG1 gene should be considered in severely mentally retarded patients (no speech-language) with severe acquired microcephaly (-4 to-6 SD) and few clinical features suggestive of Rett syndrome.
|
22739344 |
2012 |
Microcephaly
|
0.500 |
Biomarker
|
disease |
BEFREE |
We believe that the FOXG1 gene should be considered in severely mentally retarded patients (no speech-language) with severe acquired microcephaly (-4 to-6 SD) and few clinical features suggestive of Rett syndrome.
|
22739344 |
2012 |
Rett Syndrome
|
0.300 |
Biomarker
|
disease |
BEFREE |
We also predicted the structural order-disorder propensity and assessed the evolutionary rates per site of MeCP2, CDKL5, and FOXG1 to investigate the relationships between disordered structure and other related properties with RTT.
|
31717404 |
2019 |
Agenesis of corpus callosum
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
We also found that inactivation of one Foxg1 allele specifically in cortical neurons was sufficient to cause cerebral cortical hypoplasia and corpus callosum agenesis.
|
30392794 |
2018 |
Glioblastoma Multiforme
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
We also demonstrate that the two H3F3A mutations give rise to GBMs in separate anatomic compartments, with differential regulation of transcription factors OLIG1, OLIG2, and FOXG1, possibly reflecting different cellular origins.
|
23079654 |
2012 |
Glioblastoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
We also demonstrate that the two H3F3A mutations give rise to GBMs in separate anatomic compartments, with differential regulation of transcription factors OLIG1, OLIG2, and FOXG1, possibly reflecting different cellular origins.
|
23079654 |
2012 |
Dysmorphic features
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
Visual impairment in FOXG1-mutated individuals and mice.
|
27001178 |
2016 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Visual impairment in FOXG1-mutated individuals and mice.
|
27001178 |
2016 |
Muscle hypotonia
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Visual impairment in FOXG1-mutated individuals and mice.
|
27001178 |
2016 |